Log in | Register

Clinical measures for increased creatinine clearances and suboptimal antibiotic dosing

Mathias W. Pletz| Jeffrey Lipman
Editorial
Volume 39, Issue 7 / July , 2013

Pages 1322 - 1324

No abstract available.

References

  1. Rybak MJ, Lomaestro BM, Rotschafer JC, Moellering RC, Craig WA, Billeter M, Dalovisio JR, Levine DP (2009) Vancomycin therapeutic guidelines: a summary of consensus recommendations from the Infectious Diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists. Clin Infect Dis 49:325–327
    • View reference on publisher's website
    • View reference on PubMed
  2. Moise-Broder PA, Forrest A, Birmingham MC, Schentag JJ (2004) Pharmacodynamics of vancomycin and other antimicrobials in patients with Staphylococcus aureus lower respiratory tract infections. Clin Pharmacokinet 43:925–942
    • View reference on publisher's website
    • View reference on PubMed
  3. Liu C, Bayer A, Cosgrove SE, Daum RS, Fridkin SK, Gorwitz RJ, Kaplan SL, Karchmer AW, Levine DP, Murray BE, J Rybak M, Talan DA, Chambers HF (2011) Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis 52:e18–e55
    • View reference on publisher's website
    • View reference on PubMed
  4. Choi EY, Huh JW, Lim CM, Koh Y, Kim SH, Choi SH, Kim YS, Kim MN, Hong SB (2011) Relationship between the MIC of vancomycin and clinical outcome in patients with MRSA nosocomial pneumonia. Intensive Care Med 37:639–647
  5. Udy AA, Roberts JA, Lipman J (2011) Implications of augmented renal clearance in critically ill patients. Nat Rev Nephrol 7:539–543
    • View reference on publisher's website
    • View reference on PubMed
  6. Kees MG, Hilpert JW, Gnewuch C, Kees F, Voegeler S (2010) Clearance of vancomycin during continuous infusion in intensive care unit patients: correlation with measured and estimated creatinine clearance and serum cystatin C. Int J Antimicrob Agents 36:545–548
    • View reference on publisher's website
    • View reference on PubMed
  7. Llopis-Salvia P, Jimenez-Torres NV (2006) Population pharmacokinetic parameters of vancomycin in critically ill patients. J Clin Pharm Ther 31:447–454
    • View reference on publisher's website
    • View reference on PubMed
  8. Crandon JL, Ariano RE, Zelenitsky SA, Nicasio AM, Kuti JL, Nicolau DP (2011) Optimization of meropenem dosage in the critically ill population based on renal function. Intensive Care Med 37:632–638
  9. Pletz MW, Bloos F, Burkhardt O, Brunkhorst FM, Bode-Boger SM, Martens-Lobenhoffer J, Greer MW, Stass H, Welte T (2010) Pharmacokinetics of moxifloxacin in patients with severe sepsis or septic shock. Intensive Care Med 36:979–983
  10. Taccone FS, Laterre PF, Dugernier T, Spapen H, Delattre I, Wittebole X, De Backer D, Layeux B, Wallemacq P, Vincent JL, Jacobs F (2010) Insufficient beta-lactam concentrations in the early phase of severe sepsis and septic shock. Crit Care 14:R126
    • View reference on publisher's website
    • View reference on PubMed
  11. Udy AA, Varghese JM, Altukroni M, Briscoe S, McWhinney BC, Ungerer JP, Lipman J, Roberts JA (2012) Subtherapeutic initial beta-lactam concentrations in select critically ill patients: association between augmented renal clearance and low trough drug concentrations. Chest 142:30–39
    • View reference on publisher's website
    • View reference on PubMed
  12. Burkhardt O, Kumar V, Schmidt S, Kielstein JT, Welte T, Derendorf H (2010) Underdosing of ertapenem in critically ill patients with pneumonia confirmed by Monte Carlo simulations. Int J Antimicrob Agents 35:96–97
    • View reference on publisher's website
    • View reference on PubMed
  13. Freire AT, Melnyk V, Kim MJ, Datsenko O, Dzyublik O, Glumcher F, Chuang YC, Maroko RT, Dukart G, Cooper CA, Korth-Bradley JM, Dartois N, Gandjini H (2010) Comparison of tigecycline with imipenem/cilastatin for the treatment of hospital-acquired pneumonia. Diagn Microbiol Infect Dis 68:140–151
    • View reference on publisher's website
    • View reference on PubMed
  14. Roberts JA, Taccone FS, Udy AA, Vincent JL, Jacobs F, Lipman J (2011) Vancomycin dosing in critically ill patients: robust methods for improved continuous-infusion regimens. Antimicrob Agents Chemother 55:2704–2709
    • View reference on publisher's website
    • View reference on PubMed
  15. Gous AG, Dance MD, Lipman J, Luyt DK, Mathivha R, Scribante J (1995) Changes in vancomycin pharmacokinetics in critically ill infants. Anaesth Intensive Care 23:678–682
    • View reference on PubMed
  16. Shimamoto Y, Fukuda T, Tanaka K, Komori K, Sadamitsu D (2013) Systemic inflammatory response syndrome criteria and vancomycin dose requirement in patients with sepsis. Intensive Care Med. doi:10.1007/s00134-013-2909-9
  17. Baptista JP, Udy AA, Sousa E, Pimentel J, Wang L, Roberts JA, Lipman J (2011) A comparison of estimates of glomerular filtration in critically ill patients with augmented renal clearance. Crit Care 15:R139
    • View reference on publisher's website
    • View reference on PubMed
  18. Martin JH, Fay MF, Udy A, Roberts J, Kirkpatrick C, Ungerer J, Lipman J (2011) Pitfalls of using estimations of glomerular filtration rate in an intensive care population. Intern Med J 41:537–543
    • View reference on publisher's website
    • View reference on PubMed

Sign In

Connect with ICM

Top 5 Articles Editors Picks Supplement